Outpatient clinical considerations for treating COVID-19: CDC

Paxlovid and remdesivir, which goes by the brand name Veklury, are the preferred antiviral drugs for treating eligible COVID-19 patients, according to the CDC's interim outpatient clinical considerations updated June 15.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive